Divestments and COVID-19 drag down GSK’s sales

3 May 2021 - Deborah Wilkes

GlaxoSmithKline (GSK) Consumer Healthcare reported a significant drop in sales during the first quarter of 2021 as divestments and the COVID-19 pandemic took their toll.